Tilray Brands, Inc.

NASDAQ:TLRY

Drug Manufacturers - Specialty & Generic

Healthcare
$2.25 -0.84%

-$0.04 today

Market cap
$251.62M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $3.50High $23.20

Volume 5.03M

Average 4.73M

TLRY Inventory

Cash effect of the change in inventory; building inventory consumes cash.

Tilray Brands, Inc.NASDAQ: TLRY

Inventory · Q3 FY2026 · quarter ended Feb 2026

Inventory turns negative

Q3 FY2026 inventory was -$9.29M, compared with $3.89M a year earlier. Trailing-twelve-month inventory was -$37.26M. Over 3 fiscal years it compounded at -31.4% a year.

Context

  • Inventory amounted to 1.7% of revenue in FY2025, down 0.3 pp from a year earlier.
  • Inventory grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly inventory holds near -$9.29M or moves back toward the trailing-twelve-month quarterly average of -$9.31M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterFeb 2026
-$9.29M+1518.7% QoQ
Last fiscal yearMay 2025
-$18.61M-12.3% YoY
LTMFeb 2026
-$37.26M+72.8% YoY
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-338.7%——
1 year-12.3%——
3-year CAGR-31.4%——
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the cash flow

Latest · FY2025
(18.61M) USD
Year-over-year change
+12.3%

Inventory vs competitors

How TLRY compares with its peers on the latest reported figures

  • Peers report in different currencies, so inventory is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +72.8% is the lowest of 2, against a peer median of +336.2%.
  • Inventory amounts to 3.2% of revenue for TLRY, versus a peer median of 5.1%.
TLRY Competitors
Inventory for TLRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TLRYTilray Brands, Inc.LTM Feb 2026$37.26M USD+72.8%-31.4%3.2%
ACBAurora Cannabis Inc.LTM Mar 2026CA$31.7M CAD+336.2%+10.4%10.2%
SNDLSNDL Inc.LTM Mar 2026CA$0 CAD——0.0%
GLASGlass House Brands Inc—— ———
Peer median (excluding TLRY) —+336.2%+10.4%5.1%

Competitors are the stored peer set for TLRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Net Income(443.62M)(601.05M)(1.96B)(333.8M)(3B)
Depreciation & Amortization81.9M194.88M175.31M172.93M183.17M
Deferred Income Tax(30.03M)(34.71M)(43.04M)(52.97M)(166.06M)
Stock-Based Compensation00000
Change in Working Capital(61.5M)(115.68M)19.4M(12.09M)(85.85M)
Accounts Receivables(28.39M)(7.36M)5.61M(8.96M)(24.43M)
Inventory(42.6M)(57.67M)(17.42M)(21.23M)(18.61M)
Accounts Payables17.51M(56.29M)27M288.86K(31.48M)
Other Working Capital(8.01M)5.64M4.21M17.81M(11.34M)
Other Non-Cash Items399.26M333.12M1.82B183.82M2.94B
Operating Cash Flow(53.99M)(223.45M)10.65M(42.11M)(129.81M)
Capital Expenditures(46.94M)(42.94M)(28.02M)(39.85M)(45.17M)
Acquisitions (Net)88.4M15.8M(30.19M)(71.01M)(15.49M)
Purchases of Investments00(325.83M)0(3.45M)
Sales of Investments000285.75M0
Other Investing Activities14.2M0000
Investing Cash Flow55.67M(27.14M)(384.04M)174.88M(64.11M)
Debt Repayment56.22M(149.85M)(76.96M)(110.24M)(31.89M)
Common Stock Issued123.99M330.91M174.56M11.74M221.18M
Common Stock Repurchased00(1.6M)00
Dividends Paid00000
Other Financing Activities(30.13M)(19.46M)(1.5M)(3.95M)(6.1M)
Financing Cash Flow150.09M161.6M94.5M(102.45M)183.2M
Effect of Forex Changes321.14M(2.47M)(3M)(748.05K)1.56M
Net Change in Cash472.9M(91.46M)(281.89M)29.58M(9.16M)
Free Cash Flow(100.93M)(266.39M)(17.37M)(81.96M)(174.98M)

Tilray Brands, Inc.

NASDAQ:TLRY

Intrinsic Alpha fair value

Locked

Current Price

$2.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.